Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

- Numax Achieves Primary Endpoint Among High-Risk Infants Versus Current Standard of Care and Shows Reduction of Medically Attended Outpatient RSV- Related Lower Respiratory Infections -

TORONTO, May 08, 2007 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced positive results from a large prospective trial conducted for prevention of respiratory syncytial virus (RSV). The trial compared motavizumab, the investigational monoclonal antibody (MAb) also known as Numax(R), with Synagis(R) (palivizumab), the standard of care for preventing RSV hospitalization in high-risk infants. In the Phase 3 study involving 6,635 pre-term infants at high risk for RSV, with a primary endpoint of non- inferiority, motavizumab demonstrated overall 26-percent fewer RSV hospitalizations compared with Synagis (p<0.01 for non-inferiority). Additionally, motavizumab demonstrated a statistically significant 50 percent reduction in the incidence of RSV-specific medically attended outpatient lower respiratory infections (LRIs) (p<0.01) compared with Synagis. These findings were presented today in a poster entitled, Phase 3 Trial of Motavizumab, an Enhanced Potency RSV-Specific MAb for the Prevention of Serious RSV Disease in High-Risk Infants, at the Pediatric Academic Societies' Annual Meeting in Toronto, Canada.

"As RSV continues to be the leading cause of lower respiratory tract infections in infants in the United States, we are very encouraged by the results of this Phase 3 trial, which suggest that motavizumab may help to reduce the chance that our most vulnerable babies will have serious RSV disease," said Edward M. Connor, M.D., chief medical officer and executive vice president. "Data from the study showed that motavizumab was statistically superior to Synagis for the secondary endpoint of outpatient medically attended LRI caused by RSV, and thus may reduce the overall burden of RSV disease compared to the current stan
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:8/26/2014)... 2014 Blue Bell, Pennsylvania will ... a leading global Contract Research Organization (CRO), is relocating employees from ... locations into new modern Class A+ office space in ... week and marks the first phase of the relocation plan. ... said Harris Koffer , President of the Strategic Solutions Group ...
(Date:8/26/2014)... 2014 Biomedical Research Laboratories (BRL) ( www.brlscience.com ... the prestigious 2014 Inc. 500 list of America,s fastest-growing ... on this prestigious list and ranked among the most ... Biomedical Research Laboratories, CEO. "Today,s announcement represents a major ... the hard work and talent of our team. BRL ...
(Date:8/26/2014)... , Aug. 26, 2014 ... of the "Global Veterinary Diagnostics Market 2014-2018" ... Veterinary diagnostics include various tests, which are used ... livestock producers, and biomedical researchers are mainly availing ... testing (Deoxyribonucleic Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, ...
Breaking Medicine Technology:PRA Health Sciences Expands in Pennsylvania 2Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 2Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis 3
... LAS VEGAS, May 22 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin ... Christopher Moore to be the sponsor and general,partner of ... of,$1 million and up to $10 million of the ... am extremely impressed with CVBT,s wound healing drug, which ...
... Novavax, Inc. (Nasdaq:,NVAX) today announced that it ... vaccine candidate against Severe Acute Respiratory Syndrome,(SARS). The ... Institutes of Health (NIH) to continue preclinical development ... "Until now, it has been difficult to ...
Cached Medicine Technology:Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development 2Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development 3
(Date:8/27/2014)... August 27, 2014 In My Solitude, a ... Collection” to provide a growing number of women from college ... for goal setting and relaxing at the same time. , ... uses scent memory and visualization to help women stay focused ... each time they light a candle and enjoy the fragrance. ...
(Date:8/27/2014)... 2014 Michael A. Bottar ... of The Best Lawyers In America© for the practice ... Injury Litigation - Plaintiffs." , Bottar received his undergraduate ... laude graduate of Syracuse University College of Law where ... Practice" chapter of the Syracuse Law Review Survey of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 iHire ... practices as the “Most Creative Workplace” in Frederick, ... Best Places to Work Awards. , Held at ... event is a joint partnership between the Frederick ... Economic Development, Frederick County Business Development and Retention, ...
(Date:8/27/2014)... *To find out more about this ... Research on the web ( http://www.achieveclinical.com ) or contact them ... There is no cost to participate , ... Compensation may be provided for time and travel ... there are at least 5 million Americans living with fibromyalgia. ...
(Date:8/26/2014)... BambooIndustry.com, the popular online supplier of bamboo products, has ... for the online market. Along with that, the company ... items are offered at greatly discounted prices, from 15 ... on September 10, 2014. , At present, all ... shipping costs. The company wants to offer an excellent ...
Breaking Medicine News(10 mins):Health News:In My Solitude Unveils Eco Candle Line That May Improve Performance 2Health News:Michael A. Bottar Selected For Inclusion In The Best Lawyers In America© 2015 2Health News:iHire Named Most Creative Workplace in Frederick, MD 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 3Health News:Discounted, High Quality Bamboo Floorings Provided Online By BambooIndustry.com 2
... 10 Nutraceutical International Corporation (Nasdaq: NUTR ) today reported ... 30, 2009. Net sales for the fiscal 2009 fourth quarter ... of fiscal 2008. For the fourth quarter of fiscal 2009, ... compared to net income of $1.5 million, or $0.14 diluted earnings ...
... ... all women using the birth control pills Yaz or Yasmin that they may ... vein thrombosis and other significant side effects as a result of the defective ... and Yasmin —known as drospirenone, or DRSP—has been linked to an increased risk ...
... Given the rising ... be offering free testing for Chlamydia at all six affiliated campuses in the State of ... Research Officer of the Institute in a meeting with health care providers in Polk county ... (Vocus) December 10, ...
... pcRUSH.com ... technology hardware to the various Branches of the United States Federal, State/Local Governments and ... , ... (PRWEB) December 10, 2009 -- pcRUSH.com / Atman, Inc. was recently awarded a General ...
... ... Machine Tool Giveaway contest. The 5 were chosen from a pool of nearly 400 ... accepted in video or essay form. , ... Charlotte, NC (PRWEB) December 10, 2009 -- Okuma America Corporation has announced the ...
... new study to asses patient awareness of medications prescribed during ... a medication they were not, and 96% were unable to ... had been prescribed during hospitalization. These findings are published ... Inpatient medication errors represent an important patient safety issue, with ...
Cached Medicine News:Health News:Nutraceutical Reports Fiscal 2009 Year End Results 2Health News:Nutraceutical Reports Fiscal 2009 Year End Results 3Health News:Nutraceutical Reports Fiscal 2009 Year End Results 4Health News:Nutraceutical Reports Fiscal 2009 Year End Results 5Health News:Nutraceutical Reports Fiscal 2009 Year End Results 6Health News:Nutraceutical Reports Fiscal 2009 Year End Results 7Health News:Nutraceutical Reports Fiscal 2009 Year End Results 8Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 2Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 3Health News:Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN 4Health News:The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses &#8211; Dr. Abdul Rao 2Health News:The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses &#8211; Dr. Abdul Rao 3Health News:pcRUSH.com / Atman, Inc. is Awarded General Services Administration (GSA) Schedule (GS-35F-0099W) 2Health News:Okuma Real Help Machine Tool Giveaway Finalists Announced 2Health News:Study highlights lack of patient knowledge regarding hospital medications 2
Provides a combination of concentrated cold / hot and compression for the back...
... One-Piece™ Collar is completely injected molded from ... our patented chin support. , ,Our ... efficiently managed where space is limited. Color-coded ... of sizes., ,Either in a supine ...
... therapy Gel Pad. Our Gel Pad helps defeat ... reduce swelling and /or hot therapy to increase ... hot and cold therapy gel pad, place an ... can be added to each support upon request. ...
... Because when it comes to superior immobilization ... do the job., ,You already know that ... is immobilization of the c-spine. But what you ... that Jerome Medical's NECLOC ®: provides superior immobilization ...
Medicine Products: